Mod GRF 1-29
Sermorelin, Growth Hormone Releasing Hormone (1-29), hGRF(1-29)NH2
Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)
Brief Summary
The aim of this study is to assess the developmental patterns of lung function in children affected by growth hormone deficiency after one year of GH therapy.The assessment by specific questionnaires of quality of life and of parental stress index.Parameters will be evaluated at the time of the diagnosis and after 12 months of GH therapy.
Detailed Description
Observational longitudinal study in children affected by idiopathic growth hormone deficiency (GHD): lung function parameters assessment; quality of life assessment; stress parenting assessment (Pneumo GHD). The aim of this study is to assess the developmental patterns of lung function in children affected by growth hormone deficiency after one year of GH therapy.The assessment by specific questionnaires of quality of life and of parental stress index.Parameters will be evaluated at the time of the diagnosis and after 12 months of GH therapy.
Interventions
Primary Outcomes
Trial Information
NCT02507245
Completed
OBSERVATIONAL
Stefania La Grutta, MD
December 15, 2025